Skip to main content

UBS Oconnor LLC

SEC CIK
0001132716
Latest filing
Aug 14, 2026

YMAB holding history

Y-mAbs Therapeutics, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

YMAB overviewAll 13F holders of YMABFull Q4 2025 holdings

Shares (Q4 2022)
0
Sold out in Q4 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2022
Holdings of YMAB by UBS Oconnor LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20220$00.0%−44,000−100.0%Sold outHolders
Q3 202244,000$634.0K<0.1%+44,000NewHolders